Perhaps of greater interest, aberrant Cer glycosylation was seen to promote m6A‐favored pre‐mRNA splicing so as to amplify p53 mutant protein production in cancer cells carrying TP53 R273H mutation. The gene discussed is CBLN1; the disease is cancer.